Implicancias de la restricción de crecimiento intrauterino (RCIU) sobre las enfermedades metabólicas

Pasqualini, Titania.
Rev. Soc. Argent. Endocrinol. Ginecol. Reprod ; 16(1): 15-25, mayo 2009. tab, graf
Artículo en Español | LILACS, BINACIS | ID: biblio-1171273

Documentos relacionados

  1. Identification of growth patterns of preterm and small-for-gestational age children from birth to 4 years - do they catch up?
  2. Implicancias de la restricción de crecimiento intrauterino (RCIU) sobre las enfermedades metabólicas
  3. Growth Hormone and the Human Hair Follicle.
  4. The effect of growth hormone treatment on metabolic and cardiovascular risk factors is similar in preterm and term short, small for gestational age children.
  5. Prevalence of small for gestational age (SGA) and short stature in children born SGA who qualify for growth hormone treatment at 3 years of age: Population-based study.
  6. Near-Adult Height After Growth Hormone Treatment in Children Born Prematurely-Data From KIGS.
  7. Growth Hormone Therapy in the Short SGA Child: Does Time Matter?
  8. Letter to the Editor From Arroyo et al: "Timing of Puberty, Pubertal Growth, and Adult Height in Short Children Born Small for Gestational Age Treated With Growth Hormone".
  9. Response to Letter to the Editor From Arroyo et al: "Timing of Puberty, Pubertal Growth, and Adult Height in Short Children Born Small for Gestational Age Treated With Growth Hormone".
  10. The relationship between serum levels of prolactin and growth hormone in the early postnatal period.